 |
05.25.11 | New Mixed Standard for Stevia Testing to JECFA Protocol
New Mixed Standard for Stevia Testing to JECFA Protocol
May 25, 2011 7:00:00 AM
IRVINE, Calif., May 25, 2011 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), a world leader in phytochemical reference standards and contract research, announces the addition of a new stevia standard to its reference standard offering. Laboratories doing stevia analysis will now have one complete reference standard that contains all nine of the compounds needed to perform an analysis of the extract obtained from the leaves of Stevia rebaudiana Bertoni using the latest Joint FAO/WHO Expert Committee on Food Additives (JECFA) method.
| 05.19.11 | Blue Earth Successfully Concludes Agreement for Exclusive Private Label and Manufacturing Rights to Patented Lighting Controls Technology
Blue Earth Successfully Concludes Agreement for Exclusive Private Label and Manufacturing Rights to Patented Lighting Controls Technology
Shareholder Conference Call Set for May 26, 2011 At 4:15 PM, EST
May 19, 2011 12:59:00 PM
HENDERSON, Nev., May 19, 2011 (GLOBE NEWSWIRE) -- Blue Earth, Inc. (OTCBB:BBLU) is pleased to announce that it closed an agreement to acquire, for restricted common stock (150,000 shares), cash ($100,000) and a 4% royalty on gross profits, the exclusive private label and manufacturing rights to an innovative and patented lighting controls technology.
A shareholder conference call is scheduled on May 26, 2011 at 4:15 PM, EST. The call in number and access code are (877) 941-0843, conference ID is 4443286.
| 05.12.11 | ChromaDex Reports Financial Results for the First Quarter 2011
ChromaDex Reports Financial Results for the First Quarter 2011
Highlights include a 31% increase in revenue compared to first quarter 2010 and positive cash flow in the quarter
On Thursday May 12, 2011, 8:40 am EDT
IRVINE, Calif., May 12, 2011 /PRNewswire/ -- ChromaDex Corporation, (OTCBB:CDXC) an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced financial results for the first quarter of 2011. On a reported basis and calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced total revenues of approximately $2.5 million and a net loss attributable to common stockholders of $0.02 per share for the three month period ended April 2, 2011.
| 05.12.11 | CAMAC Energy Announces Gas Discovery on ZJS-03 Well, China Asset
CAMAC Energy Announces Gas Discovery on ZJS-03 Well, China Asset
May 12, 2011 8:25:00 AM
HOUSTON--(BUSINESS WIRE)-- CAMAC Energy Inc. (NYSE Amex: CAK), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, announced today the positive results from the ZJS-03 well that was successfully drilled to a total depth of 1598 meters. Mud logs during drilling confirmed the presence of gas in several intervals ranging in depth from 1489 to 1515 meters.
| 05.10.11 | Blue Earth to Expand Its Energy Efficiency Retrofit Business
Blue Earth to Expand Its Energy Efficiency Retrofit Business
On Tuesday May 10, 2011, 7:30 am EDT
HENDERSON, Nev., May 10, 2011 (GLOBE NEWSWIRE) -- Blue Earth, Inc. (OTCBB: BBLU) is pleased to announce that its subsidiary, Castrovilla Inc. ("CI") is expanding its energy efficiency retrofit model into Oregon, Washington, Idaho, Nevada, Utah, Arizona and Southern California. The business expansion will use the Blue Earth Energy Management Services ("BEEMS") trade name as we build the Blue Earth brand as a premier company in the multi-billion dollar energy efficiency services sector. BEEM is hiring additional personnel to provide energy efficiency retrofit services under the leadership of Mr. John Pink, President of CI.
| 05.04.11 | Blue Earth Signs LOI for Exclusive Private Label and Manufacturing Rights to Patented Lighting Controls Technology
Blue Earth Signs LOI for Exclusive Private Label and Manufacturing Rights to Patented Lighting Controls Technology
On Wednesday May 4, 2011, 7:30 am EDT
HENDERSON, Nev., May 4, 2011 (GLOBE NEWSWIRE) -- Blue Earth, Inc. (OTCBB: BBLU) is pleased to announce that it signed a Letter of Intent ("LOI") to acquire, for restricted common stock (150,000 shares), cash ($100,000) and a 4% royalty on gross profits, the exclusive private label and manufacturing rights to an innovative and patented lighting controls technology. This technology is based on distributed intelligence that embeds a microprocessor to control the "switch" inside a fluorescent ballast. The microprocessor can now control each individual fluorescent tube in either an "on/off" state using the existing wall switch to send instructions to the "smart ballast" which controls the on/off state of each tube. As important, each fluorescent tube can be optionally controlled by a wireless device, including a computer, which can control a network of lights in any given facility. The energy cost savings realized are immediate and long term.
| 05.03.11 | CAMAC Energy Inc. Announces First Quarter 2011 Earnings and Operational Update
CAMAC Energy Inc. Announces First Quarter 2011 Earnings and Operational Update
May 3, 2011 3:01:00 PM
HOUSTON--(BUSINESS WIRE)-- CAMAC Energy Inc. (NYSE Amex: CAK), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, today announced a net loss of $28.2 million, or $0.18 per diluted share for the quarter ended March 31, 2011. This loss includes the remaining estimated Oyo well #5 intervention expenses of $24.4 million, or $0.16 per diluted share. For the same period in 2010, CAMAC Energy reported a net loss of $3.2 million, or $0.07 per diluted share.
| 05.03.11 | Frost & Sullivan Recognizes ChromaDex for the Unique Potential Its Commercially Available Product Offers in the Human Nutrition Industry
Frost & Sullivan Recognizes ChromaDex for the Unique Potential Its Commercially Available Product Offers in the Human Nutrition Industry
IRVINE, CA -- (MARKET WIRE) -- 05/03/11 -- Based on its recent analysis of the health ingredients market, Frost & Sullivan recognizes ChromaDex, Inc (OTCBB: CDXC) with the 2010 North American Frost & Sullivan Award for Most Promising Ingredient of the Year for the unique ingredient it offers under the brand name pTeroPure™ pterostilbene, a 99% pure form of trans-pterostilbene -- a compound found in small berries, other small fruits and in the bark and heartwood of some trees. It is a phytoalexin produced by plants to fight infections from bacteria or fungi and has shown promising health benefits while gaining rapid traction in the nutraceutical industry.
| 04.13.11 | CAMAC Energy Releases Report for OML 120 & 121 Blocks Prepared by Netherland, Sewell & Associates, Inc.
CAMAC Energy Releases Report for OML 120 & 121 Blocks Prepared by Netherland, Sewell & Associates, Inc.
On Wednesday April 13, 2011, 9:25 am
HOUSTON--(BUSINESS WIRE)-- CAMAC Energy Inc. (NYSE Amex: CAK), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, announced today the results of an independent engineering report prepared by Netherland, Sewell & Associates, Inc. (NSAI) estimating the total resource in place in CAMAC Energy's OML 120 & 121 Blocks situated offshore Nigeria.
| 04.12.11 | CAMAC ENERGY INC. APPOINTS NEW CEO;
CAMAC ENERGY INC. APPOINTS NEW CEO;
$25 MILLION CREDIT FACILITY COMMITTED
HOUSTON, TEXAS – April 11, 2011 -- CAMAC Energy Inc. (NYSE: Amex: CAK), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, today announced that Chief Executive Officer and President, Byron A. Dunn, has decided with the Board of Directors to resign his positions with the Company, effective immediately.
| 04.07.11 | CAMAC Energy Announces Spudding Progress of ZJS-3 Well in China
CAMAC Energy Announces Spudding and Progress of ZJS-3 Well in China
On Thursday April 7, 2011, 9:25 am
HOUSTON--(BUSINESS WIRE)-- CAMAC Energy, Inc. (NYSE: Amex: CAK) is pleased to announce the spudding and progress of its ZJS-3 well in China. Drilling is expected to take between 40 and 60 days to reach the well’s target depth of between 4,500 and 5,500 feet. Currently the penetrating depth is 3,300 feet drilled towards the main target formations. Mud logs have already shown gas readings from several penetrated intervals.
| 04.06.11 | Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene
Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene
On Wednesday April 6, 2011, 8:00 am EDT
IRVINE, Calif., April 6, 2011 /PRNewswire/ -- Life Extension, a global authority on nutrition, health, and wellness and a provider of dietary supplements, has launched a product featuring ChromaDex's (OTCBB: CDXC) pTeroPure pterostilbene, which is now available in many local health food stores and natural retailers.
| 04.04.11 | ChromaDex Appoints Curtis Lockshin, Ph.D., to its Board of Directors
ChromaDex Appoints Curtis Lockshin, Ph.D., to its Board of Directors
On Monday April 4, 2011, 8:00 am EDT
IRVINE, Calif., April 4, 2011 /PRNewswire/ --ChromaDex Corporation (OTCBB:CDXC),an innovative natural products company that provides proprietary, science-based solutions and ingredients, today announced that Curtis A. Lockshin, Ph.D., was appointed to its Board of Directors.
| 03.30.11 | Nutraceutical International Corporation Launches Product Featuring ChromaDex's pTeroPure Pterostilbene
Nutraceutical International Corporation Launches Product Featuring ChromaDex's pTeroPure Pterostilbene
On Wednesday March 30, 2011, 8:00 am EDT
IRVINE, Calif., March 30, 2011 /PRNewswire/ -- ChromaDex (OTCBB:CDXC) today announced that Nutraceutical International Corporation (Nasdaq:NUTR ), one of the nation's largest manufacturers of nutritional supplements, has launched a product featuring ChromaDex's pTeroPure™ Pterostilbene in its Solaray® Guaranteed Potency line of products.
| 03.16.11 | ChromaDex Reports Financial Results for the Fourth Quarter and Year Ended 2010
ChromaDex Reports Financial Results for the Fourth Quarter and Year Ended 2010
Highlights include increased revenues by 31% over prior year, the launch of first novel ingredient, expansion of executive team and over $2 million cash on hand
On Wednesday March 16, 2011, 8:40 am EDT
IRVINE, Calif., March 16, 2011 /PRNewswire/ -- ChromaDex Corporation, (OTCBB: CDXC) an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced financial results of its Fiscal Year ending January 1, 2011. On a reported basis and calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced total revenues of approximately $7.6 million and a net loss attributable to common stockholders of $0.04 per share for the one year period ended January 1, 2011. As of January 1, 2011, cash, cash equivalents, and marketable securities totaled over $2.2 million.
| 03.11.11 | Frost & Sullivan Awards ChromaDex With Most Promising Ingredient of the Year Award
Frost & Sullivan Awards ChromaDex With Most Promising Ingredient of the Year Award
On Friday March 11, 2011, 8:00 am EST
IRVINE, Calif., March 11, 2011 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), announced today that the Company has been awarded the 2010 North American Health Ingredients Most Promising Ingredient of the Year award by the independent research company, Frost & Sullivan, for its proprietary branded ingredient pTeroPure™ Pterostilbene.
| 03.02.11 | ChromaDex and Bruker Optics Sign Agreement to Expedite Dietary Supplement Testing for Compliance With FDA Good Manufacturing Practice Requirements
ChromaDex and Bruker Optics Sign Agreement to Expedite Dietary Supplement Testing for Compliance With FDA Good Manufacturing Practice Requirements
The collaboration will provide the industry with true 'plug and play' identity testing technology
On Wednesday March 2, 2011, 8:00 am EST
IRVINE, Calif. and WOODLANDS, Texas, March 2, 2011 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), and Bruker Optics Inc., a subsidiary of Bruker Corporation (Nasdaq:BRKR), announced today a co-development and co-marketing agreement that will promote a new approach to dietary supplement testing. The collaboration will capitalize on the extensive phytochemical and botanical reference standard capabilities of ChromaDex and will initially focus on the near infrared spectrometer (NIR) technology created by Bruker Optics. The parties anticipate extending the relationship to include other Bruker analytical technologies.
| 02.23.11 | Blue Earth Appoints Laird Q. Cagan as Chairman of the Board of Directors and Appoints Johnny R. Thomas to the Board
Blue Earth Appoints Laird Q. Cagan as Chairman of the Board of Directors and Appoints Johnny R. Thomas to the Board
On Wednesday February 23, 2011, 1:57 pm
HENDERSON, Nev., Feb. 23, 2011 /PRNewswire/ -- Blue Earth, Inc. (OTCBB: BBLU) is pleased to announce that Laird Q. Cagan has been elected as Chairman of the Board of Directors. The Board's decision to elect Mr. Cagan as Chairman reflects its strategy to focus on acquiring companies in the rapidly growing, multi-billion dollar, energy efficiency sector and to develop and acquire cutting-edge technologies for the energy efficiency sector and across the clean tech industry.
| 02.15.11 | CAMAC Energy Inc. Announces the Acquisition of Offshore Nigerian Contract Rights
CAMAC Energy Inc. Announces the Acquisition of Offshore Nigerian Contract Rights
On Wednesday February 16, 2011, 9:00 am
HOUSTON--(BUSINESS WIRE)-- CAMAC Energy Inc. (NYSE Amex: CAK), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, today announced that on February 15, 2011, it completed the acquisition of the remaining interest held by Allied Energy Plc and certain of its affiliates (“Allied”) in a Production Sharing Contract (the “PSC”) which relates to Oil Mining Leases 120 and 121 granted to Allied by the Federal Republic of Nigeria. CAMAC Energy has now acquired Allied’s full interest under the PSC, and has recombined CAMAC Energy’s interest in the Oyo Field within OML 120 that it acquired from Allied in April 2010.
| 01.24.11 | Liviakis Financial Communications Increases Stake In Blue Earth to 11 Percent
Liviakis Financial Communications Increases Stake In Blue Earth to 11 Percent
Extends Investor Relations Contract With Blue Earth Through November 2012
Blue Earth's Net Shareholder Equity Exceeds the $4 million New York-American Stock Exchange Requirement
On Monday January 24, 2011, 8:30 am EST
HENDERSON, Nev., Jan. 24, 2011 /PRNewswire/ -- Blue Earth, Inc. (OTCBB:BBLU) announced today that it raised $499,999.30 from its Investor Relations Representative, John Liviakis, in a private placement, which was negotiated in December and closed on December 31, 2010. Mr. Liviakis purchased 434,782 shares, which increases his position in Blue Earth to 11 percent of the total 13,134,994 shares issued and outstanding after the recent acquisition of Castrovilla.
| 01.20.11 | Blue Earth and Castrovilla Successfully Complete Merger
Blue Earth and Castrovilla Successfully Complete Merger
Acquisition Establishes Company's Position in the Rapidly Growing Energy Efficiency Sector
On Thursday January 20, 2011, 8:30 am EST
HENDERSON, Nev., Jan. 20, 2011 /PRNewswire/ -- Blue Earth, Inc. (OTCBB:BBLU) is pleased to announce that it has successfully closed its previously announced Letter of Intent (LOI) to acquire its first company, Castrovilla, Inc. Blue Earth's acquisition of Castrovilla is effective as of January 1, 2011 for $2.15 million payable in 1,279,762 restricted shares of Blue Earth common stock valued at $1.68 per share and $200,000 for debt retirement.
| 01.04.11 | ChromaDex Awarded Phase II Small Business Innovation Research Grant by National Science Foundation
ChromaDex Awarded Phase II Small Business Innovation Research Grant by National Science Foundation
$500,000 awarded for commercial development of next generation plant-based antioxidants called anthocyanins.
On Tuesday January 4, 2011, 8:00 am EST
IRVINE, Calif., Jan. 4, 2011 /PRNewswire/ -- ChromaDex Corporation (OTCBB:CDXC), a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property, announced today that the National Science Foundation (NSF) awarded the Company a $500,000 Phase II Small Business Innovation Research (SBIR) Grant to further the commercial development of several plant-based antioxidants called anthocyanins for use in nutraceutical, food, beverage and cosmetic products. The project, entitled, "SBIR Phase II: Microbial Production of Selected Anthocyanins," will allow ChromaDex to complete validation of AnthoPure™ technology for the manufacturing of anthocyanins via fermentation.
| 12.22.10 | CAMAC ENERGY INC. RAISES $20.0 MILLION IN REGISTERED DIRECT OFFERING
CAMAC ENERGY INC. RAISES $20.0 MILLION IN REGISTERED DIRECT OFFERING
HOUSTON, TEXAS – December 22, 2010 – CAMAC Energy Inc. (NYSE Amex: CAK) (the “Company” or “CAMAC Energy”), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, today announced that the Company has entered into definitive agreements dated December 21, 2010 with certain accredited investors (the “Investors”) to sell in a registered direct offering an aggregate of approximately 9.09 million shares of its common stock at a price of $2.20 per share, and five-year warrants to purchase up to approximately 4.54 million shares of common stock with an initial exercise price of $2.20 per share, exercisable immediately. Thirty days after the closing date, the exercise price of the Warrants will increase to $2.62 per share for the remainder of the term of the Warrants. CAMAC Energy will receive aggregate gross proceeds of approximately $20.0 million from the offering before deducting offering fees and expenses. The offering is expected to close on or around December 27, 2010, subject to customary closing conditions.
| 12.02.10 | ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
ChromaDex to be a definitive source for Vitamin K2 MK-7 reference standards and analytical methods
On Thursday December 2, 2010, 12:56 pm
IRVINE, Calif., Dec. 2, 2010 /PRNewswire-FirstCall/ -- ChromaDex Corporation (OTCBB:CDXC), a leader in phytochemical reference standards and related contract analysis and research services, today announced that it has entered into a global agreement with Kappa Bioscience AS (Oslo, Norway) to supply analytical reference standards, quality control methods and related analytical testing services for Vitamin K2, Menaquinone-7(MK-7) in raw materials and finished goods.
| 12.01.10 | CAMAC Energy Announces Early Commencement of Oyo #5 Well Intervention
CAMAC Energy Announces Early Commencement of Oyo #5 Well Intervention
On Wednesday December 1, 2010, 1:00 pm
HOUSTON--(BUSINESS WIRE)-- CAMAC Energy Inc. (NYSE Amex: CAK), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, today announced that it has been notified by its partner, Nigerian Agip Exploration Limited (“NAE”), that the well intervention planned on the Oyo #5 well, located in the Oyo Field located offshore Nigeria, is scheduled to commence on December 4, 2010 with the mobilization of the Transocean Marianas to the field. The mobilization is commencing earlier than previously anticipated due to the availability of the Marianas, a fourth generation Earl & Wright Sedco 700 design semi-submersible drilling unit that will be performing the intervention. CAMAC Energy acquired a 60% contractual interest in the Oyo Field in April 2010 and NAE is the Oyo Field’s operator and a subsidiary of ENI SpA, one of the world’s largest international energy companies.
| 11.29.10 | CAMAC Energy Announces Gas Discovery on the Zijinshan, China Asset
CAMAC Energy Announces Gas Discovery on the Zijinshan, China Asset
On Monday November 29, 2010, 9:30 am
HOUSTON--(BUSINESS WIRE)-- CAMAC Energy Inc. (NYSE Amex:CAK), a U.S.-based energy company engaged in the exploration, development and production of oil and gas, today announced the positive results from the ZJS-02 well that was successfully drilled to a total depth of 1784 meters. Mud logs during drilling confirmed the presence of gas in several intervals ranging in depth from 1471 to 1742 meters.
| 11.29.10 | Blue Earth to Grant Special One-Time Dividend, an "A Warrant", to its December 31st Shareholders of Record
Blue Earth to Grant Special One-Time Dividend, an 'A Warrant', to Its December 31st, 2010 Shareholders of Record
November 17th Shareholder Conference Call Available at www.blueearthinc.com
On Monday November 29, 2010, 8:30 am EST
HENDERSON, Nev., Nov. 29, 2010 /PRNewswire-FirstCall/ -- Blue Earth, Inc. (OTCBB:BBLU), announced today it will grant a special one-time dividend to its December 31, 2010 shareholders of record. This special dividend will be one A Warrant for every two shares held on December 31, 2010 and is exercisable at $3 per share for a three year term.
| 10.28.10 | ChromaDex Names Pharmaceutical Industry Veteran William F. Spengler as President
ChromaDex Names Pharmaceutical Industry Veteran William F. Spengler as President
On Thursday October 28, 2010, 8:00 am EDT
IRVINE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- ChromaDex Corporation (OTCBB:CDXC), a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property, announced today that the Company appointed William F. Spengler to President of the Company, effective November 15, 2010. Mr. Spengler brings a strong and diversified background to the position, having held leadership roles in pharmaceutical companies such as Guilford Pharmaceuticals, MGI Pharma, and Bristol-Myers Squibb as well as Endo Pharmaceuticals where he currently serves as a Director. In his new role, Mr. Spengler will have responsibility for the expansion and implementation of the company's strategy as ChromaDex increases its leadership position in the natural products industry.
| 10.12.10 | ChromaDex Announces the Availability of an Expanded 2011 Phytochemical Catalog
ChromaDex Announces the Availability of an Expanded 2011 Phytochemical Catalog
Comprehensive product catalog to be a definitive source for dietary supplement cGMP requirements
On Tuesday October 12, 2010, 8:00 am EDT
IRVINE, Calif., Oct. 12 /PRNewswire/ -- ChromaDex Corporation (OTCBB:CDXC), a leader in phytochemical reference standards and related contract analysis and research services, today released a 2011 phytochemical product catalog designed to provide the dietary supplement industry with the analytical and research tools needed to meet the requirements of the Food and Drug Administration's (FDA) Good Manufacturing Practice Regulations.
| 10.12.10 | CAMAC Energy Inc. Enters Agreement to Acquire Contract Rights Located Offshore Nigeria
CAMAC Energy Inc. Enters Agreement to Acquire Contract Rights Located Offshore Nigeria
On Tuesday October 12, 2010, 8:00 am EDT
HARTSDALE, N.Y.--(BUSINESS WIRE)-- CAMAC Energy Inc. (NYSE Amex: CAK) (the “Company”), a US-based energy company engaged in the development and production of oil and gas in West Africa and China, announced today that it has entered into a binding Heads of Agreement (the “Agreement”) with Allied Energy Resources Nigeria Limited and certain of its affiliates (“Allied”) to acquire all of Allied’s remaining interest in a Production Sharing Contract (the “PSC”) which relates to those certain Oil Mining Leases 120 and 121 (“OML 120” and “OML 121”) granted to Allied by the Federal Republic of Nigeria with respect to oil and gas assets offshore of Nigeria (the “Non-Oyo Contract Rights”). The Company previously acquired all of Allied’s interest with respect to the Oyo Field, located in OML 120 (the “Oyo Contract Rights”) under the PSC in a transaction that closed in April 2010. Upon consummation of the transaction contemplated under the Agreement, the Company will have acquired Allied’s full interest in the PSC and recombined the Oyo field within OML 120. The transaction is expected to close on or before November 30, 2010 and is subject to certain closing conditions.
| 09.20.10 | CAMAC Energy Chairman Dr. Kase Lawal Named by President Obama for Appointment as Adviser for Trade Policy and Negotiations
CAMAC Energy Chairman Dr. Kase Lawal Named by President Obama for Appointment as Adviser for Trade Policy and Negotiations
On Monday September 20, 2010, 8:00 am EDT
HARTSDALE, N.Y.--(BUSINESS WIRE)--CAMAC Energy Inc. (NYSE Amex:CAK) is pleased to announce today the Company’s Non-Executive Chairman, Dr. Kase Lawal, has been selected by President Obama for appointment to his Advisory Committee for Trade Policy and Negotiations.
|
|
|
|
